Doctor profile · Federal record
Dr. Clarissa Malafronte, APRN
Nurse Practitioner · Tampa, FL
- NPI 1972051241
- Accepts Medicare
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
3622 Madaca Ln
Tampa, FL 336182057
(813) 513-3643
fax (813) 605-5465 - Additional location
-
11601 Sheldon RD
Tampa, FL 336264306
(813) 324-6630
fax (813) 926-1500 - Mailing address
-
4919 Memorial Hwy Ste 150
Tampa, FL 336347516
Credentials & registration
- NPI registered
- September 2016 — 10 yrs on file
- Profile last updated
- April 3, 2023
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Florida #APRN9316294
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972051241. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
976
Distinct HCPCS
9
Medicare allowed
$44,671
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 388 | 68 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 198 | 155 | $75 | |
17000 |
Destruction of precancer skin growth, 1 growth | 102 | 91 | $41 | |
17110 |
Destruction of skin growth, 1-14 growths | 77 | 71 | $88 | |
11102 |
Biopsy of related skin growth, first growth | 75 | 69 | $73 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 68 | 68 | $93 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 32 | 27 | $106 | |
11103 |
Biopsy of related skin growth, each additional growth | 20 | 15 | $41 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 16 | 14 | $47 |
In context: peer comparison
Among 151 peers in this city , average services per provider: 148. This provider delivers 6.6× the peer median.Open Payments
Industry payments received
All-time total
$3,140
Transactions
112
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| UCB, Inc. | 24 | $516.56 | |
| Janssen Biotech, Inc. | 8 | $358.88 | |
| ABBVIE INC. | 13 | $330.32 | |
| Arcutis Biotherapeutics, Inc. | 8 | $323.71 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $289.57 | |
| Galderma Laboratories, L.P. | 7 | $230.53 | |
| GENZYME CORPORATION | 4 | $227.85 | |
| Incyte Corporation | 8 | $161.01 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $151.64 | |
| LEO Pharma Inc. | 4 | $145.85 | |
| PFIZER INC. | 5 | $76.87 | |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $61.07 | |
| Novartis Pharmaceuticals Corporation | 3 | $59.19 | |
| ConvaTec Inc. | 2 | $43.71 | |
| Amgen Inc. | 2 | $42.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
263
Patients
149
Total drug cost
$6,449
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 56 | 30 | $1,249 |
| Triamcinolone Acetonide | Generic | 47 | 42 | $558 |
| Doxycycline Hyclate | Generic | 27 | 18 | $534 |
| Hydrocortisone | Generic | 23 | 20 | $104 |
| Nystatin | Generic | 23 | 0 | $221 |
| Mupirocin | Generic | 16 | 14 | $94 |
| Betamethasone Dipropionate | Generic | 15 | 0 | $984 |
| Clobetasol Propionate | Generic | 15 | 14 | $1,081 |
| Hydroxyzine Hcl | Generic | 14 | 0 | $101 |
| Spironolactone | Generic | 14 | 0 | $164 |
Frequently asked questions
What is Dr. Clarissa Malafronte's medical specialty?
Dr. Clarissa Malafronte practices Nurse Practitioner in Tampa, FL.
Where does Dr. Clarissa Malafronte practice?
Dr. Clarissa Malafronte practices at 3622 Madaca Ln, Tampa, FL 336182057. Office phone: 8135133643.
What is Dr. Clarissa Malafronte's NPI?
Dr. Clarissa Malafronte's National Provider Identifier (NPI) is 1972051241, issued by NPPES.
Does Dr. Clarissa Malafronte accept Medicare assignment?
Yes. Dr. Clarissa Malafronte accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Clarissa Malafronte commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.